Advancing Exceptional Research on HIV/AIDS (R01)

 

This FOA will support highly innovative R01 applications on HIV/AIDS and drug abuse and will complement the Avant-Garde program. The Avant-Garde award http://ww2.drugabuse.gov/about/organization/arp/AVGP.htm supports individuals who conduct high-risk, high-payoff research and does not require a detailed research plan. This FOA focuses on innovative research projects that have the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. Applications submitted under this FOA are required to have a detailed research plan and preliminary data. This FOA is open to both individual researchers and research teams and is not limited to any one area of research.

Deleted 01/17/2013 (Archived.) RFA-DA-13-008 Agency: Department of Health and Human Services
Office: National Institutes of Health Grant Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 12/17/2012 This program does not have cost sharing or matching requirements. NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-008.html FBOWebmaster@OD.NIH.GOV $1,500,000.00